BIOGEN INC. Long Term Debt

Quick Answer

BIOGEN INC. reported Long Term Debt of $6.28 billion for the year ending 2022.

  • BIOGEN INC. showed an increase of +0.1% in Long Term Debt from 2021 to 2022.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 15, 2023.
  • XBRL data for this metric is available from 2012 to 2022 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $726.39 million | Q3 2013: $694.89 million | Q1 2014: $591.01 million | Q2 2014: $586.09 million | Q3 2014: $583.98 million | Q1 2015: $580.67 million | Q2 2015: $576.21 million | Q3 2015: $6.53 billion | Q1 2016: $6.54 billion | Q2 2016: $6.54 billion | Q3 2016: $6.53 billion | Q1 2017: $5.95 billion | Q2 2017: $5.95 billion | Q3 2017: $5.94 billion | Q1 2018: $5.93 billion | Q2 2018: $5.93 billion | Q3 2018: $5.93 billion | Q1 2019: $5.94 billion | Q2 2019: $5.95 billion | Q3 2019: $4.46 billion | Q1 2020: $4.46 billion | Q2 2020: $7.42 billion | Q3 2020: $7.43 billion | Q1 2021: $7.27 billion | Q2 2021: $7.27 billion | Q3 2021: $6.27 billion | Q1 2022: $6.28 billion | Q2 2022: $6.28 billion | Q3 2022: $6.28 billion | Q4 2022: $6.28 billion | Q1 2023: $6.28 billion | Q2 2023: $6.28 billion | Q3 2023: $6.79 billion | Q4 2023: $6.79 billion | Q1 2024: $6.29 billion | Q2 2024: $6.29 billion | Q3 2024: $4.55 billion | Q4 2024: $4.55 billion | Q1 2025: $4.55 billion | Q2 2025: $6.28 billion | Q3 2025: $6.29 billion.
  • Over the full 11 years of available data (2012 to 2022), BIOGEN INC.'s Long Term Debt has grown by 813.7%.
  • Historical annual values: Fiscal year 2022: $6.28 billion | Fiscal year 2021: $6.27 billion | Fiscal year 2020: $7.43 billion | Fiscal year 2019: $4.46 billion | Fiscal year 2018: $5.94 billion | Fiscal year 2017: $5.94 billion | Fiscal year 2016: $6.51 billion | Fiscal year 2015: $6.52 billion | Fiscal year 2014: $580.30 million | Fiscal year 2013: $592.43 million | Fiscal year 2012: $687.40 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: